We report the roles of BCL2L2 (BCL-W), BCL2, and Beclin-1 (BECN1) in affecting responsiveness to ICI-resistance, and describe how anti-apoptotic BCL2 family members are involved in determining breast cancer cell fate. This evidence concerns the gene BCL2L2 and breast cancer.